Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)

PHASE2CompletedINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

June 30, 2007

Study Completion Date

July 31, 2007

Conditions
Rhinitis, Allergic, Seasonal
Interventions
DRUG

Ciclesonide HFA

75 mcg Ciclesonide HFA versus Placebo

DRUG

Ciclesonide HFA

150 mcg Ciclesonide HFA versus Placebo

DRUG

Ciclesonide HFA

300 mcg Ciclesonide HFA versus Placebo

DRUG

Placebo

Placebo

Trial Locations (31)

15241

Altana/Nycomed, Pittsburgh

19013

Altana/Nycomed, Upland

19422

Altana/Nycomed, Blue Bell

20814

Altana/Nycomed, Bethesda

22015

Altana/Nycomed, Burke

23226

Altana/Nycomed, Richmond

27607

Altana/Nycomed, Raleigh

29414

Altana/Nycomed, Charleston

30281

Altana/Nycomed, Stockbridge

30501

Altana/Nycomed, Gainsville

31406

Altana/Nycomed, Savannah

46208

Altana/Nycomed, Indianapolis

55402

Altana/Nycomed, Minneapolis

63141

Altana/Nycomed, St Louis

66210

Altana/Nycomed, Overland Park

68046

Altana/Nycomed, Papillion

68505

Altana/Nycomed, Lincoln

78130

Altana/Nycomed, New Braunfels

78229

Altana/Nycomed, San Antonio

78750

Altana/Nycomed, Austin

80230

Altana/Nycomed, Denver

80907

Altana/Nycomed, Colorado Springs

84020

Altana/Nycomed, Draper

92123

Altana/Nycomed, San Diego

92691

Altana/Nycomed, Mission Viejo

92868

Altana/Nycomed, Orange

97213

Altana/Nycomed, Portland

97504

Altana/Nycomed, Medford

97520

Altana/Nycomed, Ashland

08558

Altana/Nycomed, Skillman

08724

Altana/Nycomed, West Brick

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY